Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 1/20 | 0.53 |
| ▸ | TTK | P33981 | 1/20 | 0.53 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.53 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.53 |
| ▸ | F10 | P00742 | 9/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 5/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.46 |
| ▸ | KDR | P35968 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C18 | P33260 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30863559 | 0.86 | F10 (0.59) | AURKATTKAURKBINCENPF10 | |
| SCHEMBL27195758 | 0.84 | AURKA (0.53) | AURKATTKAURKBINCENPF10 | |
| SCHEMBL30863478 | 0.84 | HDAC3 (0.52) | HDAC3HDAC8FGFR1 | |
| Hydrochloric Acid SCHEMBL27195736 | 0.80 | AURKA (0.52) | AURKATTKAURKBINCENPF10 | |
| SCHEMBL27195914 | 0.79 | HDAC3 (0.59) | AURKATTKAURKBINCENPF10 | |
| SCHEMBL30863502 | 0.79 | HDAC3 (0.59) | AURKATTKAURKBINCENPF10 | |
| SCHEMBL27195706 | 0.78 | TRPV1 (0.58) | AURKATTKAURKBINCENPF10 | |
| Hydrochloric Acid SCHEMBL30863551 | 0.77 | F10 (0.58) | AURKATTKAURKBINCENPF10 | |
| Hydrochloric Acid SCHEMBL30863555 | 0.75 | F10 (0.56) | AURKATTKAURKBINCENPF10 | |
| Hydrochloric Acid SCHEMBL30863442 | 0.75 | NPC1 (0.54) | AURKATTKAURKBINCENPF10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | disclosed |